CDC Allows the J&J COVID-19 Vaccine to Resume Despite Blood Clot Risks

CDC Allows the J&J COVID-19 Vaccine to Resume Despite Blood Clot Risks


It’s business as usual for Big Pharma.

After a brief stoppage of the J&J COVID-19 jab, an independent advisory panel for the CDC voted for it to resume on the FDA’s emergency use authorization.

So, the drug is still not FDA approved and there are known life-threatening risk factors.

Trending: Congresswoman criticized for using term ‘birthing people’

No thanks, I’ll pass on that experimental cocktail.

Here’s more:

The CDC and FDA lifted the pause on Johnson & Johnson’s COVID-19 vaccine Friday night.

But unlike Pfizer and Moderna’s shots, J&J’s single-dose vaccine will likely come with a warning about the potential risk of rare blood clots.@NikkiBattiste has more https://t.co/lAN3wGgJNa pic.twitter.com/vidPSRANmT

— CBS Evening News (@CBSEveningNews) April 24, 2021

FDA & CDC lift recommended pause on J&J #covid19 vaccine, say use of the vaccine should resume pic.twitter.com/2qufr6IMPu

— Meg Tirrell (@megtirrell) April 23, 2021

Breaking News: The FDA ended its recommended pause on the Johnson & Johnson vaccine, clearing the way for states across

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!
Thanks for sharing!
Send this to a friend